Why the study?
The balance of benefits and risks of anticoagulant therapy in elderly patients with atrial fibrillation remains an important clinical consideration.
Whether to anticoagulate: Toward a more reasoned approach T he article by hagerty and rich in this issue of the Cleveland Clinic Journal of Medicine 1 covers an important topic-whether elderly patients with atrial fi brillation should receive anticoagulant therapy for it, or whether the risk of bleeding with this therapy outweighs the benefi t of preventing stroke.
No takes yet. Share an insight, caveat, or question.
Theodore T. Suh (2017) conducted an editorial in Atrial fibrillation. Anticoagulation therapy vs. No anticoagulation was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: